In the competitive nutraceutical landscape, GreenIuronic® establishes a new benchmark for therapeutic efficacy, substantiated by pioneering research. Utilizing a dual-model approach, combining a simulated osteoarthritic joint environment with an EFSA-validated 3D human intestinal organoid system, scientists have demonstrated the superior performance of this botanical powerhouse over conventional fermented sodium hyaluronate. The study confirms that GreenIuronic® delivers a multi-dimensional advantage for joint health:
For manufacturers, GreenIuronic® represents a strategic opportunity to transition from generic supplementation to a science-backed, high-absorption solution designed to help managing osteoarthritic conditions and restore joint mobility at the cellular level.